199 related articles for article (PubMed ID: 33383048)
21. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.
Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618
[TBL] [Abstract][Full Text] [Related]
22. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
[TBL] [Abstract][Full Text] [Related]
23. Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.
Ferrante A; Martire A; Pepponi R; Varani K; Vincenzi F; Ferraro L; Beggiato S; Tebano MT; Popoli P
Neurobiol Dis; 2014 Nov; 71():193-204. PubMed ID: 25132555
[TBL] [Abstract][Full Text] [Related]
24. Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells.
Gines S; Ivanova E; Seong IS; Saura CA; MacDonald ME
J Biol Chem; 2003 Dec; 278(50):50514-22. PubMed ID: 14522959
[TBL] [Abstract][Full Text] [Related]
25. Loss of striatal 90-kDa ribosomal S6 kinase (Rsk) is a key factor for motor, synaptic and transcription dysfunction in Huntington's disease.
Anglada-Huguet M; Giralt A; Rué L; Alberch J; Xifró X
Biochim Biophys Acta; 2016 Jul; 1862(7):1255-66. PubMed ID: 27063456
[TBL] [Abstract][Full Text] [Related]
26. Decreased FAK activity and focal adhesion dynamics impair proper neurite formation of medium spiny neurons in Huntington's disease.
Lee HN; Hyeon SJ; Kim H; Sim KM; Kim Y; Ju J; Lee J; Wang Y; Ryu H; Seong J
Acta Neuropathol; 2022 Sep; 144(3):521-536. PubMed ID: 35857122
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease.
Laprairie RB; Kelly ME; Denovan-Wright EM
Neuropharmacology; 2013 Sep; 72():47-57. PubMed ID: 23602984
[TBL] [Abstract][Full Text] [Related]
28. VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.
Ibrahim KS; El Mestikawy S; Abd-Elrahman KS; Ferguson SSG
J Neurosci; 2023 Jun; 43(23):4365-4377. PubMed ID: 37055181
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor 9 reduces TBHP-induced oxidative stress in chondrocytes and diminishes mouse osteoarthritis by activating ERK/Nrf2 signaling pathway.
Pan YN; Jia C; Yu JP; Wu ZW; Xu GC; Huang YX
Int Immunopharmacol; 2023 Jan; 114():109606. PubMed ID: 36700776
[TBL] [Abstract][Full Text] [Related]
30. Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin.
Naia L; Ribeiro M; Rodrigues J; Duarte AI; Lopes C; Rosenstock TR; Hayden MR; Rego AC
Neuropeptides; 2016 Aug; 58():73-81. PubMed ID: 26876526
[TBL] [Abstract][Full Text] [Related]
31. Altered anterograde axonal transport of mitochondria in cultured striatal neurons of a knock-in mouse model of Huntington's disease.
Wu C; Yin H; Fu S; Yoo H; Zhang M; Park H
Biochem Biophys Res Commun; 2024 Jan; 691():149246. PubMed ID: 38029540
[TBL] [Abstract][Full Text] [Related]
32. Soluble SORLA Enhances Neurite Outgrowth and Regeneration through Activation of the EGF Receptor/ERK Signaling Axis.
Stupack J; Xiong XP; Jiang LL; Zhang T; Zhou L; Campos A; Ranscht B; Mobley W; Pasquale EB; Xu H; Huang TY
J Neurosci; 2020 Jul; 40(31):5908-5921. PubMed ID: 32601248
[TBL] [Abstract][Full Text] [Related]
33. Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.
Ribeiro M; Silva AC; Rodrigues J; Naia L; Rego AC
Toxicol Sci; 2013 Dec; 136(2):487-99. PubMed ID: 24008831
[TBL] [Abstract][Full Text] [Related]
34. Modulation of nuclear REST by alternative splicing: a potential therapeutic target for Huntington's disease.
Chen GL; Ma Q; Goswami D; Shang J; Miller GM
J Cell Mol Med; 2017 Nov; 21(11):2974-2984. PubMed ID: 28524599
[TBL] [Abstract][Full Text] [Related]
35. Twist1 Plays an Anti-apoptotic Role in Mutant Huntingtin Expression Striatal Progenitor Cells.
Jen WP; Chen HM; Lin YS; Chern Y; Lee YC
Mol Neurobiol; 2020 Mar; 57(3):1688-1703. PubMed ID: 31813126
[TBL] [Abstract][Full Text] [Related]
36. Robust Neuritogenesis-Promoting Activity by Bis(heptyl)-Cognitin Through the Activation of alpha7-Nicotinic Acetylcholine Receptor/ERK Pathway.
Hu SQ; Cui W; Mak SH; Choi CL; Hu YJ; Li G; Tsim KW; Pang YP; Han YF
CNS Neurosci Ther; 2015 Jun; 21(6):520-9. PubMed ID: 25917415
[TBL] [Abstract][Full Text] [Related]
37. Turning Death to Growth: Hematopoietic Growth Factors Promote Neurite Outgrowth through MEK/ERK/p53 Pathway.
Gao M; Zhao LR
Mol Neurobiol; 2018 Jul; 55(7):5913-5925. PubMed ID: 29119536
[TBL] [Abstract][Full Text] [Related]
38. The proinflammatory cytokine, interleukin-17A, augments mitochondrial function and neurite outgrowth of cultured adult sensory neurons derived from normal and diabetic rats.
Habash T; Saleh A; Roy Chowdhury SK; Smith DR; Fernyhough P
Exp Neurol; 2015 Nov; 273():177-89. PubMed ID: 26321687
[TBL] [Abstract][Full Text] [Related]
39. SH2B1beta enhances fibroblast growth factor 1 (FGF1)-induced neurite outgrowth through MEK-ERK1/2-STAT3-Egr1 pathway.
Lin WF; Chen CJ; Chang YJ; Chen SL; Chiu IM; Chen L
Cell Signal; 2009 Jul; 21(7):1060-72. PubMed ID: 19249349
[TBL] [Abstract][Full Text] [Related]
40. Induction of neurite outgrowth in PC12 cells by alpha -phenyl-N-tert-butylnitron through activation of protein kinase C and the Ras-extracellular signal-regulated kinase pathway.
Tsuji M; Inanami O; Kuwabara M
J Biol Chem; 2001 Aug; 276(35):32779-85. PubMed ID: 11438521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
